LRRK2 and Parkinson disease: Previous biochemical analysis demonstrates the kinase and GTPase activity of LRRK2, and these activities are apparently altered by several PD-linked mutations [3], [4], [5], [6], leading to the hypothesis of “gain-of-function” in LRRK2 mutants with enhanced kinase activity [5], [7], [8].